Drummond Paris, President of Kowa Research Europe, said: "Thelaunch of Livazo in Lebanon represents a milestone for Kowa as ourfirst product in this region. It will be the first of many launchesin Europe, the Middle East and North Africa during 2011. We arekeen to offer the benefits of Livazo to patients across the globe." References 1. Livazo Summary of Product Characteristics 2. Ose L. Pitavastatin: finding its place in therapy. Ther AdvChronic Dis. 2011. Published online before print. January 26, 2011,doi: 10.1177/2040622310389227 3. Budinski D, Arneson V, Hounslow N, Gratsiansky N. Pitavastatincompared with atorvastatin in primary hypercholesterolemia orcombined dyslipidemia. Clin. Lipidol. 2009;4:291-302 4. Ose L, Budinski D, Hounslow N, Arneson V. Comparison ofpitavastatin with simvastatin in primary hypercholesterolaemia orcombined dyslipidaemia. Curr Med Res Opin 2009;25: 2755-64 5. Stender S, Hounslow N. Robust efficacy of pitavastatin andcomparable safety to pravastatin. Atherosclerosis Suppl. 2009;10:e945 6. Ose L, Budinski D, Hounslow N, Arneson V: Long-term treatmentwith pitavastatin is effective and well tolerated by patients withprimary hypercholesterolemia or combined dyslipidemia.Atherosclerosis 2010; 202-208 7. World Health Organization. Cardiovascular diseases fact sheet.Accessed on 14 February, 2011. See here. 8. Rady, A. Is lifestyle affecting the risk of non-communicablediseases in Lebanon? Human & Health 2010;13:15-17 9. Data on file (study 309) 10. Data on file (study 310) About Livazo Pitavastatin (a statin) is a fully synthetic and highly potentinhibitor of HMG-CoA reductase used for primaryhypercholesterolemia and combined dyslipidemia. Pitavastatin has aunique cyclopropyl group on the base structure common to the statinclass. Since its 2003 launch in Japan, pitavastatin has accumulatedmillions of patient-years of exposure. Many of these patients haveco-morbidities and are taking multiple medications. Kowa receivedFDA approval of pitavastatin (Livalo(R)) for the treatment ofprimary hyperlipidemia or mixed dyslipidemia in August 2009 and itwas launched in the U.S. in June 2010. Additionally, Kowa filed inEurope in August 2008 using the decentralised authorisationprocedure and received regulatory approval in mid 2010. In much ofEurope, pitavastatin will be marketed by Recordati. Pitavastatinwill be available in three dosage strengths (1 mg, 2 mg and 4 mg). *1. Co-marketing by the two companies under one brand name, Livalo . The annual sales of Livalo tablets in Japan reached $520 millionin 2010. *2 Kowa (Shanghai) Pharma Consulting Co. Ltd., a wholly-ownedsubsidiary of Kowa, is obtaining and providing information tophysicians and hospitals in China to ensure proper use ofpitavastatin. *3 In the United States, Kowa Pharmaceuticals America, Inc.(Headquarters in Alabama, US), a wholly-owned subsidiary of Kowa,sell and market pitavastatin with a co-promotion partner, Eli Lilly(Headquarters in Indiana, US). *4 In Europe, pitavastatin will be distributed by KowaPharmaceutical Europe Co. Ltd. (Headquarters in Wokingham, UK), awholly-owned subsidiary of Kowa, and Recordati (Headquarters inMilan, Italy), a partner distributor. About Algorithm Algorithm, pharmaceutical manufacturer based in Lebanon, aims atbeing the trusted regional partner to medical and patientcommunities and is committed to delivering quality care inpharmaceutical therapies. It operates in the Middle East and NorthAfrica region with a product portfolio consisting of innovativeproducts as well as differentiated generics, focusing mainly on thefollowing therapeutic areas: cardiology, endocrinology, neurology,gynaecology and urology. Algorithm has built partnerships with manyinternational companies, amongst which is Kowa. Source: Kowa Pharmaceutical Europe. We are high quality suppliers, our products such as Skin Rejuvenation Machine Manufacturer , IPL Hair Removal Machine Manufacturer for oversee buyer. To know more, please visits E-Light Laser Hair Removal.
Related Articles -
Skin Rejuvenation Machine Manufacturer, IPL Hair Removal Machine Manufacturer,
|